UBS Group’s AEON Biopharma AEON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24K | Buy |
31,600
+28,643
| +969% | +$21.8K | ﹤0.01% | 7012 |
|
|
2025
Q1 | $1.72K | Buy |
2,957
+2,279
| +336% | +$1.32K | ﹤0.01% | 8142 |
|
|
2024
Q4 | $26.4K | Sell |
678
-122
| -15% | -$4.74K | ﹤0.01% | 6476 |
|
|
2024
Q3 | $60.5K | Buy |
+800
| New | +$60.5K | ﹤0.01% | 5492 |
|
|
2024
Q1 | – | Sell |
-9
| Closed | -$4.67K | – | 8060 |
|
|
2023
Q4 | $4.67K | Buy |
+9
| New | +$4.67K | ﹤0.01% | 6628 |
|
|
2023
Q1 | – | Sell |
-11
| Closed | -$8.06K | – | 8432 |
|
|
2022
Q4 | $8.06K | Sell |
11
-33
| -75% | -$24.2K | ﹤0.01% | 7629 |
|
|
2022
Q3 | $32K | Buy |
44
+29
| +193% | +$21.1K | ﹤0.01% | 5702 |
|
|
2022
Q2 | $11K | Hold |
15
| – | – | ﹤0.01% | 6739 |
|
|
2022
Q1 | $11K | Buy |
+15
| New | +$11K | ﹤0.01% | 7228 |
|